Clin2
NCT07045688Possibly a fitRecruiting

Vonoprazan for Helicobacter pylori infection

H. Pylori Infection

Part of Digestive system clinical trials.

This trial tests vonoprazan-based treatments to see if they can effectively clear H. pylori infection. It may help if you have not been treated for H. pylori before.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
150 people
Ages
19 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have a confirmed Helicobacter pylori infection (by biopsy or a stool test).
  • You have never been treated for H. pylori before.
  • You are not allergic to vonoprazan or other study medications.
  • You can complete the full treatment course and attend follow-up visits.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06959368Recruiting· Phase 4
New H. pylori treatment vs standard triple therapy

This trial compares a newer drug (vonoprazan) plus antibiotics to the standard triple therapy for eradicating H. pylori infection in the stomach. It may be a good option if you have stomach symptoms like indigestion, acid reflux, or a non-bleeding ulcer and have not been treated for H. pylori before.

Hyderabad, Telangana
NCT07130253Not yet recruiting
Vonoprazan-based therapy for stubborn H. pylori infection

This trial tests a new combination of medicines to treat H. pylori infection that has not gone away after at least two previous treatments. It may help if you have not had success with standard therapy and are looking for another option.

Taipei
NCT07293910Recruiting· Phase 2
Comparing treatments for H. pylori infection

This trial tests whether a new type of acid-reducing drug (vonoprazan) works better than a common one (proton pump inhibitor) when combined with vitamin D or probiotics to clear H. pylori, a bacteria that can cause stomach problems. If you have H. pylori and haven't been treated for it before, this study may be for you.

Tanta
NCT07624422Not yet recruiting· Phase 4
Two antibiotic combinations for H. pylori stomach infection

This study compares two different antibiotic treatment plans for H. pylori, a common stomach bacteria that causes ulcers and digestive problems. The trial tests whether a higher dose of one medication (vonoprazan) works better than a different antibiotic combination.

Damascus
NCT07757919Not yet recruiting· Phase 4
14-day treatment for H. pylori infection

This trial tests a 14-day treatment using two medicines, vonoprazan and minocycline, to get rid of an H. pylori infection in the stomach. It aims to see if this combination is safe and works well, and might be a simpler option for people who haven't been treated for H. pylori before.

NCT07537634Recruiting· Phase 4
New stomach acid medicine versus standard treatment for H. pylori infection

This trial compares two different antibiotic combinations to treat H. pylori, a common stomach bacteria that causes indigestion and ulcers. One uses a newer acid-blocking medicine (vonoprazan) and the other uses a standard one (esomeprazole), both paired with antibiotics.

Dhaka

Hear when a new H. Pylori Infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.